Ivabeat OD 10 Tablet PR
Marketer
Cipla Ltd
Salt Composition
Ivabradine (10mg)
Overview Ivabeat OD 10 Tablet PR
Isosorbide mononitrate (Ivabeat OD 10 Tablet PR equivalent) is prescribed for angina pectoris (chest pain stemming from heart conditions) and chronic congestive heart failure. Its mechanism involves improving cardiac efficiency by reducing heart rate, thus mitigating chest discomfort and lowering the risk of hospital admission for heart failure. Dosage varies based on the specific condition being treated. As treatment is typically lifelong, discontinuation requires prior consultation with a physician. Administer orally with food at the same time daily. Overdosage may result in bradycardia (slow heart rate), fatigue, and shortness of breath; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic abnormalities. Serious adverse effects, such as syncope (fainting) and significant cardiac rhythm changes, demand urgent medical intervention. Refrain from driving until the medication's effects are known. Contraindicated in patients with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, hypotension, or recently exacerbated heart failure. This medication interacts negatively with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Uses of Ivabeat OD 10 Tablet PR
Managing angina pectoris and heart failure.
Major Benefits of Ivabeat OD 10 Tablet PR:
Follow your physician's instructions or consult the product label for dosage information. Consume Ivabeat OD 10 Tablet PR with food.
Common Side effects of Ivabeat OD 10 Tablet PR:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivabeat OD 10 Tablet PR:
Follow your doctor's instructions or refer to the product label for guidance. Consume Ivabeat OD 10 Tablet PR with a meal.
How Ivabeat OD 10 Tablet PR works:
Cardio-Rhythm 10mg tablets are prescribed to manage elevated heart rates. Their mechanism involves slowing the heartbeat, thereby decreasing the heart's oxygen demand and improving its overall performance.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivabeat OD 10 Tablet PR is not known to be safe. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ivabeat OD 10 Tablet PR during pregnancy carries a high risk. Pregnant women should consult their physician; research in animals and pregnant women indicates substantial potential harm to the fetus.
Breast feedingUNSAFE
The medication Ivabeat OD 10 Tablet PR is contraindicated for breastfeeding mothers due to potential infant toxicity. Evidence indicates the drug may harm the nursing infant.
DrivingUNSAFE
Driving ability may be impaired by Ivabeat OD 10 Tablet PR, a medication that can induce transient visual disturbances, primarily phosphenes. The potential for these light flashes should be considered, particularly during nighttime driving.
KidneyCAUTION
Exercise caution when prescribing Ivabeat OD 10 Tablet PR to individuals with severe renal impairment. Dosage modification may be necessary. Physician consultation is advised. Data regarding Ivabeat OD 10 Tablet PR use in patients with severe kidney disease is limited.
LiverCAUTION
Patients with liver impairment should use Ivabeat OD 10 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is advised. Ivabeat OD 10 Tablet PR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ivabeat OD 10 Tablet PR :
Omit any missed dose of Ivabeat OD 10 Tablet PR and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Ivabeat OD 10 Tablet PR
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Actions | Sodium channel blockers targeting the sinoatrial node |




